Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets on Intragastric and Intraesophageal Acidity

NCT03037606 is registered in ClinicalTrials.gov with Neutec Ar-Ge San ve Tic A.Ş as lead sponsor.

NCT NCT03037606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03037606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets on Intragastric and Intraesophageal Acidity
Lead sponsor
Neutec Ar-Ge San ve Tic A.Ş
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2017
Completion date
December 11, 2018
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease